Tower Research Capital LLC TRC Boosts Holdings in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Posted by Anthony Miller on Apr 28th, 2025

Tower Research Capital LLC TRC raised its holdings in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) by 148.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,061 shares of the company’s stock after purchasing an additional 16,768 shares during the period. Tower Research Capital LLC TRC owned 1.59% of Invesco Nasdaq Biotechnology ETF worth $604,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of IBBQ. Raymond James Financial Inc. purchased a new stake in Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at approximately $888,000. Advisory Services Network LLC boosted its stake in shares of Invesco Nasdaq Biotechnology ETF by 5.8% during the fourth quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock valued at $1,154,000 after acquiring an additional 2,922 shares during the last quarter. Finally, Strategic Financial Concepts LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter worth about $1,699,000.

Invesco Nasdaq Biotechnology ETF Trading Down 1.2 %

NASDAQ:IBBQ opened at $20.62 on Monday. Invesco Nasdaq Biotechnology ETF has a 12-month low of $17.84 and a 12-month high of $24.84. The firm has a market cap of $37.32 million, a price-to-earnings ratio of 22.40 and a beta of 0.61. The company’s 50-day moving average is $21.27 and its two-hundred day moving average is $22.18.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 24th were given a dividend of $0.0402 per share. The ex-dividend date of this dividend was Monday, March 24th.

Invesco Nasdaq Biotechnology ETF Profile

(Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.